Interventional Radiology Department, Gustave Roussy Institut, Villejuif, France.
J Vasc Interv Radiol. 2010 Nov;21(11):1681-8. doi: 10.1016/j.jvir.2010.08.003.
To evaluate the feasibility, functionality, and dysfunctions of an arterial port catheter implanted via the femoral artery.
From November 2001 to May 2008, 93 consecutive patients (mean age 57 years old) with unresectable hepatic colorectal metastases were referred for intraarterial chemotherapy. The arterial port catheters were percutaneously implanted via the femoral artery. The catheter tips were placed as "free-floating" in the common hepatic artery (technique 1), "fixed" in the gastroduodenal artery (technique 2), or inserted in a segmental hepatic artery (technique 3). Embolization of the right gastric artery was always attempted.
The technical success rate of the femoral approach was 94% (n = 88 of 93). Intraarterial chemotherapy (average 7.3 courses) was administered to 84 patients. Migration and occlusion of the catheters occurred in 12% (n = 10 of 84) and 11% (n = 9 of 84) of patients, and extrahepatic perfusion occurred in 30% (n = 25 of 84) of patients. Catheter migration occurred significantly more frequently with technique 1 (50%; n = 3 of 6) than with technique 2 (11%; n = 7 of 64; P = .03) or technique 3 (0%; n = 0 of 14; P = .02). Occurrence of gastroduodenal ulcerations was significantly lower (P = .01) when embolization of the right gastric artery was performed (8%; n = 4 of 48) than when it was not (28%; n = 11 of 36). The success rate of embolization of the right gastric artery significantly improved (P = .006) from the first half of patients treated to the second half, resulting in a significant (P = .02) decrease in the occurrence of ulcerations from 28% (n = 12 of 42) in the first half of patients treated to 7% (n = 3 of 42) in the second half.
Percutaneous femoral placement of an arterial port catheter is highly feasible. Right gastric artery embolization and use of techniques 2 and 3 are good predictive factors for long-term functionality.
评估经股动脉植入动脉端口导管的可行性、功能性和功能障碍。
自 2001 年 11 月至 2008 年 5 月,对 93 例不可切除的结直肠肝转移患者(平均年龄 57 岁)进行了经动脉化疗。经皮经股动脉植入动脉端口导管。导管尖端放置在肝总动脉(技术 1)“自由漂浮”、胃十二指肠动脉(技术 2)“固定”或节段性肝动脉(技术 3)内。始终尝试对右胃动脉进行栓塞。
股动脉入路的技术成功率为 94%(93 例中的 88 例)。对 84 例患者进行了经动脉化疗(平均 7.3 个疗程)。导管迁移和闭塞分别发生在 12%(84 例中的 10 例)和 11%(84 例中的 9 例)的患者中,30%(84 例中的 25 例)患者出现肝外灌注。技术 1(50%;n=3/6)的导管迁移发生率明显高于技术 2(11%;n=7/64;P=0.03)或技术 3(0%;n=0/14;P=0.02)。当进行右胃动脉栓塞时,胃十二指肠溃疡的发生率明显较低(P=0.01)(8%;n=4/48),而不进行栓塞时为 28%(n=11/36)。右胃动脉栓塞的成功率从治疗的前半部分到后半部分明显提高(P=0.006),导致溃疡的发生率从前半部分的 28%(n=12/42)显著下降到后半部分的 7%(n=3/42)(P=0.02)。
经股动脉穿刺植入动脉端口导管具有高度可行性。右胃动脉栓塞以及使用技术 2 和 3 是长期功能的良好预测因素。